CT colleges launch data science programs
Connecticut colleges are launching data science programs to train a new generation of analytics workers. The University of Connecticut’s board of trustees recently approved a...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Connecticut colleges are launching data science programs to train a new generation of analytics workers. The University of Connecticut’s board of trustees recently approved a...
A team of Yale scientists and engineers has developed a wearable COVID-19 detector that samples the air for the virus and can alert users to an exposure. The...
Since Rallybio launched in 2018, the Connecticut-based company has been laser-focused on the development of “transformative therapeutics” for patients suffering from rare and ultra-rare diseases. The leadership...
MDMA (3,4-methylenedioxymethamphetamine) is an active ingredient in the illicit street drug known as ecstasy or molly. People in dance clubs and raves use illicit MDMA...
Read the full article in your browser here. Insperity, a small business consultant for more than 30 years, provides an array of human resource solutions...
Biohaven acquired exclusive global rights to develop and sell a novel pain drug from Belgium’s KU Leuven university, the New Haven biotech reports. The deal involves...
Arvinas recently signed a blockbuster $2.4 billion deal with Pfizer. The bankroll will fund additional trials of the Arvinas breast cancer drug, alone and in combination...
Read the full email here. Welcome to BioCT’s first Career Newsletter! You can expect an issue every other Tuesday. This is your resource for all career related...
Rallybio has provided an update on recent accomplishments and announced expected upcoming milestones. “Our mission is to build Rallybio into a leading biotechnology company, with a...
Biohaven reports it has completed its transaction with Pfizer to sell the migraine drugs rimegepant and zavegepant outside of the U.S. The deal — potentially worth $1.24 billion...